X-TOLE4

Enrolling By Invitation
99 years or below
All
Phase N/A
2 participants needed
1 Location

Brief description of study

This study aims to assess the safety and tolerability of long-term therapy with XEN1101 in subjects with FOS or PGTCS who have completed Study XPF-010-301, XPF-010-302, or XPF-010-303.  Participants MUST HAVE completed one of the prior studies in order to participate.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All
Updated on 17 Jun 2025. Study ID: 24-2138
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research